Olga Danilevskaya - Johnston IA, US Milo J. Aukerman - Newark DE, US Pedro Hermon - Johnston IA, US Evgueni Ananiev - Johnston IA, US David Mark Shirbroun - West Des Moines IA, US Michael G. Muszynski - Des Moines IA, US
The invention provides isolated floral transition nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering floral transition in plants. The invention further provides regulatory elements, recombinant expression cassettes, host cells, and transgenic plants.
Delayed Flowering Time Gene (Dlf1) In Maize And Uses Thereof
An isolated polynucleotide encoding a delayed flowering gene (DLF1) is provided, as is the isolated DLF1 protein, peptide portions thereof, and functional fragments of the DLF1. Also provided is a transgenic plant, which contains in its genome a transgene containing the polynucleotide encoding the DLF1 protein, or a nucleotide sequence complementary to the encoding polynucleotide. In addition, methods of identifying a nucleotide sequence and/or a heterologous protein that is specifically bound by the DLF1 protein, methods of using the isolated polynucleotide (or encoded polypeptide), for example, to modulate plant cell growth and/or development, are provided.
Olga Danilevskaya - Johnston IA, US Milo J. Auckerman - Newark DE, US Pedro Hermon - Johnston IA, US Evgueni Ananiev - Johnston IA, US David Mark Shirbroun - West Des Moines IA, US Michael G. Muszynski - Johnston IA, US
Assignee:
Pioneer Hi-Bred International, Inc. - Johnston IA
International Classification:
C12N 15/82 C12N 15/29 C12N 5/10 A01H 5/00
US Classification:
800278, 8003201, 800320, 800298, 536 241, 435410
Abstract:
The invention provides isolated floral transition nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering floral transition in plants. The invention further provides regulatory elements, recombinant expression cassettes, host cells, and transgenic plants.
Olga Danilevskaya - Johnston IA, US Milo J Auckerman - Newark DE, US Pedro Hermon - Johnston IA, US Evgueni Ananiev - Johnston IA, US David Mark Shirbroun - West Des Moines IA, US Michael G Muszynski - Johnston IA, US
Assignee:
Pioneer Hi-Bred International, Inc. - Johnston IA E.I. duPont de Nemours and Company - Wilmington DE
The invention provides isolated floral transition nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering floral transition in plants. The invention further provides regulatory elements, recombinant expression cassettes, host cells, and transgenic plants.
Nucleic Acid And Amino Acid Sequences Encoding A De Novo Dna Methyltransferase
The present invention provides nucleic acids encoding polypeptides which encode a de novo DNA methyltransferase. These nucleic acids can be used to stabilize transgene expression in transgenic plants, to alter the yield or biochemical qualities of plants to silencing targeted genes in plants in vivo.
Olga Danilevskaya - Johnston IA, US Milo J. Aukerman - Newark DE, US Pedro Hermon - Johnston IA, US Evgueni Ananiev - Johnston IA, US David Mark Shirbroun - West Des Moines IA, US Michael G. Muszynski - Johnston IA, US
Assignee:
E.I. DU PONT DE NEMOURS AND COMPANY - Wilmington DE PIONEER HI-BRED INTERNATIONAL, INC. - Johnston IA
The invention provides isolated floral transition nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering floral transition in plants. The invention further provides regulatory elements, recombinant expression cassettes, host cells and transgenic plants.
OLGA DANILEVSKAYA - Johnston IA, US Milo J. Aukerman - Newark DE, US Pedro Hermon - Johnston IA, US Evgueni Ananiev - Johnson IA, US David Mark Shirbroun - West Des Moines IA, US Michael G. Muszynski - Johnston IA, US
Assignee:
E.I. DuPont de Nemours and Company - Wilmington DE Pioneer Hi-Bred International, Inc. - Johnston IA
The invention provides isolated floral transition nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering floral transition in plants. The invention further provides regulatory elements, recombinant expression cassettes, host cells and transgenic plants.
Pyruvate Dehydrogenase Kinase Polynucleotides, Polypeptides And Uses Thereof
Douglas D. Randall - Columbia MO Jay J. Thelen - Columbia MO Jan A. Miernyk - Peoria IL Michael G. Muszynski - Des Moines IA Vincent J. H. Sewalt - West Des Moines IA
Assignee:
Pioneer Hi-Bred International, Inc. - Des Moines IA University of Missouri - Columbia MO
International Classification:
C12N 504 C12N 1529 C12N 1582 A01H 500 A01H 510
US Classification:
800284
Abstract:
The invention provides methods and compositions relating to altering carbohydrate metabolism and/or composition of plants. The invention provides isolated nucleic acids and their encoded proteins, expression cassettes, host cells, transgenic plants, and antibody compositions.
National Skills Development at Comerica Bank, Organization Development at Sterling Bank
Location:
San Antonio, Texas
Industry:
Banking
Work:
Comerica Bank - Dallas, Texas, San Antonio, Texas, Detroit, Michigan, Phoenix, Arizona since Jul 2011
National Skills Development
Sterling Bank - Dallas, Texas, Houston, Texas since Jan 2008
Organization Development
First Horizon Bank - Dallas, TX Jun 2005 - Jan 2008
National Expansion Training Specialist
First Horizon Bank - Livonia, MI Dec 2003 - Jun 2005
Financial Services Regional Manager
Key Bank - Ann Arbor, MI Jul 2002 - Dec 2003
Team Leader
Education:
Western Michigan University 1995 - 2000
Skills:
Training & Development Sales Management Training Skills Sales Skills Training Training Assessment Performance Assessment Developing New Markets Leadership Development Coaching Mentoring Banking Compliance Performance Management Team Building Employee Relations Hiring Organizational Development Training Employee Training Change Management
Early anecdotal reports showed that it might be useful, but later on, studies have pretty much conclusively shown that it doesnt delay hospitalizations, it doesnt prevent going to the ICU, it doesnt change the rate of dying, said infectious diseases specialist Dr. Michael Muszynski.
Date: Dec 07, 2021
Category: More news
Source: Google
FDA this week to consider Pfizer COVID-19 vaccine for 5- to 11-year-olds
Since the safety profile is almost identical to that in adults, theres no reason to believe this vaccine shouldnt be as useful in children as it is in adults, according to pediatric infectious disease expert Dr. Michael Muszynski.
Date: Oct 24, 2021
Category: More news
Source: Google
Bag Lunch a Foodborne Illness Risk for Preschoolers: Study
Michael Muszynski, professor of pediatric infectious diseases at the Florida State University College of Medicine in Tallahassee, called the results of the study "concerning, since even lunches packed with multiple ice packs reached unsafe temperatures that would encourage the growth of bacteria th